Clinical Trial Update: NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NAD supplementation to prevent progressive neurological disease in Ataxia Telangiectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• NAD Supplementation

Snippet

Sponsor: University Hospital, Akershus | Conditions: Ataxia Telangiectasia | Phase 2 | Status: ACTIVE_NOT_RECRUITING